ClinVar Miner

Submissions for variant NM_005245.4(FAT1):c.10757T>C (p.Met3586Thr)

gnomAD frequency: 0.00904  dbSNP: rs115705222
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV000966933 SCV001114292 benign not provided 2024-01-22 criteria provided, single submitter clinical testing
GeneDx RCV000966933 SCV001823278 likely benign not provided 2023-05-25 criteria provided, single submitter clinical testing See Variant Classification Assertion Criteria.
Department of Pathology and Laboratory Medicine, Sinai Health System RCV000966933 SCV001553063 likely benign not provided no assertion criteria provided clinical testing The FAT1 p.Met3586Thr variant was not identified in the literature nor was it identified in ClinVar, Cosmic or LOVD 3.0. The variant was identified in dbSNP (ID: rs115705222) and in control databases in 768 of 280608 chromosomes (12 homozygous) at a frequency of 0.002737 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: African in 707 of 24192 chromosomes (freq: 0.02922), Latino in 52 of 35370 chromosomes (freq: 0.00147), Other in 3 of 7132 chromosomes (freq: 0.000421) and European (non-Finnish) in 6 of 128422 chromosomes (freq: 0.000047), while the variant was not observed in the Ashkenazi Jewish, East Asian, European (Finnish), and South Asian populations. The p.Met3586 residue is conserved in mammals and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) provide inconsistent predictions regarding the impact to the protein; this information is not very predictive of pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as likely benign.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.